22 December 2023
22 December 2023 Wainua (eplontersen) granted first-ever regulatory approval in the US for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated amyloidosis US FDA…
21 December 2023
At a meeting of the Board of Directors held on 20 December 2023, the final accounts for the year ended 30 September 2023 were…
21 December 2023 Concurrent Technologies Plc (the “Company”) Concurrent Technologies Secures Key VME Contract Win Concurrent Technologies to supply VME Boards to major Defence…
Hargreaves Services plc (“Hargreaves” or the “Group”) Trading Update, Notice of Interim Results and Enhanced Dividend Payout Hargreaves Services plc (AIM: HSP), a diversified group…
GlobalData Plc (AIM: DATA; “GlobalData”, “the Company”, “the Group”) GlobalData announces a Group reorganisation and enters into a transformational investment agreement with Inflexion for…
21 December 2023 CARR’S GROUP PLC FULL YEAR RESULTS For the year ended 2 September 2023 Carr’s Group plc (CARR.L), (”Carr’s, the ”Company”, or the…
20 December 2023
GOODWIN PLC CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS for the half year ended 31st October 2023 CHAIRMAN’S STATEMENT I am pleased to report our half-year…
18 December 2023
Jemperli (dostarlimab) plus Zejula (niraparib) combination significantly improved progression-free survival in primary advanced or recurrent endometrial cancer in RUBY Part 2 Phase III trial · Dostarlimab plus chemotherapy…